Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Test Used to Battle West Nile Virus

By LabMedica International staff writers
Posted on 26 Sep 2012
The West Nile Virus (WNV) laboratory test is performed when a person who may have had recent exposure to the virus shows possible signs and symptoms of an infection.

The test is able to confirm whether the infection exists, allowing physicians to take action to control its impact and in severe cases, this might include hospital care where patients can receive supportive treatment including intravenous fluids, help with breathing, and nursing care. More...


Laboratory diagnosis of WNV infections is generally accomplished by testing of serum or cerebrospinal fluid (CSF) to detect virus-specific IgM and neutralizing antibodies. There are four WNV IgM ELISA kits from different manufacturers that are commercially available in the USA and are approved by US Food and Drug Administration (FDA; Silver Springs, MD, USA). In serious or fatal cases, the nucleic acid amplification test (NAAT), histopathology with immunohistochemistry and virus culture of autopsy tissues can also be useful. Only a few state laboratories or other specialized laboratories are capable of doing this specialized testing.

The NAAT technique is used because it measures the WNV’s genetic material, the test can detect an infection before the antibody test. This test is routinely used to screen donated units of blood, as well as donated tissue and organs. It also can be used to test birds and mosquito pools for WNV, often before any people have been identified with the disease, which helps public health experts track the virus’s spread through the community or region. Severe symptoms of WNV can include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis.

A record-breaking 1,590 human cases of WNV have been reported in the USA during 2012, including 65 deaths, according to the US Centers for Disease Control and Prevention (CDC; Atlanta GA, USA). Alan Mertz, MA, the president of the American Clinical Laboratory Association (Washington, DC, USA), said, "The test was developed quickly to respond to WNV when it first appeared in the USA. The test is a good example of the kind of innovative tests that clinical laboratories have discovered quickly in response to new and emerging medical crises, such as human immunodeficiency virus (HIV), herpes meningitis, severe acute respiratory syndrome (SARS), Influenza A subtype H1N1, and Avian flu.”

Related Links:

US Food and Drug Administration

US Centers for Disease Control and Prevention

American Clinical Laboratory Association




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.